Xenon Pharmaceuticals Stock Target Price and Analyst Consensus
| XENE Stock | USD 37.02 1.29 3.37% |
The current analyst and expert consensus on Xenon Pharmaceuticals is Strong Buy, with 11 strong buy opinions. The current projected Xenon Pharmaceuticals target price consensus is 57.67 with 16 analyst opinions. Check out Macroaxis Advice on Xenon Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Xenon Stock refer to our How to Trade Xenon Stock guide.The most common way Xenon Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Xenon Pharmaceuticals executives and customers to further validate their buy or sell advice. Xenon Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Xenon Pharmaceuticals target price to derive its highest and lowest estimates based on projected price volatility of 2.1498.
Lowest Forecast 52.48 | Highest Forecast 64.01 | Target Price 57.67 |
Xenon |
It's important to approach Xenon Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Xenon Pharmaceuticals Target Price Consensus
Xenon target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Xenon Pharmaceuticals' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 16 | Strong Buy |
Most Xenon analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Xenon stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Xenon Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationXenon Pharmaceuticals Target Price Projection
Xenon Pharmaceuticals' current and average target prices are 37.02 and 57.67, respectively. The current price of Xenon Pharmaceuticals is the price at which Xenon Pharmaceuticals is currently trading. On the other hand, Xenon Pharmaceuticals' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Xenon Pharmaceuticals Market Quote on 1st of March 2025
Target Price
Analyst Consensus On Xenon Pharmaceuticals Target Price
Xenon Pharmaceuticals Analyst Ratings
Xenon Pharmaceuticals' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Xenon Pharmaceuticals stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Xenon Pharmaceuticals' financials, market performance, and future outlook by experienced professionals. Xenon Pharmaceuticals' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Xenon Pharmaceuticals price targets
Xenon Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Xenon Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at Xenon Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Xenon Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Xenon Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Xenon Pharmaceuticals is a key component of Xenon Pharmaceuticals valuation and have some predictive power on the future returns of a Xenon Pharmaceuticals.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Momentum Invested few shares | |
 | Banking Invested over 30 shares | |
 | Investor Favorites Invested few shares | |
 | Driverless Cars Invested over 60 shares | |
 | Disruptive Technologies Invested few shares | |
 | Automobiles and Trucks Invested over 60 shares | |
 | Chemicals Invested over 30 shares | |
 | Hedge Favorites Invested few shares | |
 | Social Domain Invested over 20 shares |
Check out Macroaxis Advice on Xenon Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Xenon Stock refer to our How to Trade Xenon Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Please note, the presentation of Xenon Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Xenon Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Xenon Pharmaceuticals' management manipulating its earnings.